title: Redefining surgery for gastric cancer.
abstract: BACKGROUND: Despite encouraging retrospective and non-randomized trials, two large prospective, randomized trials of D1 vs D2 resections show double the mortality in the D2 group, with no increase in long-term survival. However, the D2 resection still offers the only hope of cure when N2 nodes are involved. We propose a reclassification of the International Union Against Cancer TNM "N" staging to a system with an anatomical basis that is useful in defining the surgery performed. Junctional nodes lying between the N1 and N2 tiers will act as a guide to surgery. Where these nodes are uninvolved, the probability of gastric bed (N2) involvement is low and the radical D2 dissection with its higher mortality and morbidity can be avoided.CONCLUSION: Such "stage-appropriate" surgery will reduce the number of D2 resections while ensuring that patients with N2 disease are not denied curative surgery. A prospective, randomized, controlled trial of targeted surgery is required.
authors.affiliation: Department of Surgery, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, UK.
authors.forename: J. L.
authors.initials: JL
authors.lastname: Whiting
authors.forename: M. T.
authors.initials: MT
authors.lastname: Hallissey
authors.forename: D. C.
authors.initials: DC
authors.lastname: Rowlands
authors.forename: J. W. L.
authors.initials: JW
authors.lastname: Fielding